Comprehensive analysis and validation reveal potential MYCN regulatory biomarkers associated with neuroblastoma prognosis

References

• Ambros, P. F., Ambros, I. M., Brodeur, G. M., Haber, M., Khan, J., Nakagawara, A., Schleiermacher, G., Speleman, F., Spitz, R., London, W. B., Cohn, S. L., Pearson, A. D. J., & Maris, J. M. (2009). International consensus for neuroblastoma molecular diagnostics: Report from the International Neuroblastoma Risk Group (INRG) Biology Committee. British Journal of Cancer, 100(9), 1471–1482. https://doi.org/10.1038/sj.bjc.6605014
   PubMed Web of Science ®Google Scholar
• Banh, R. S. (2016). PTP1B controls non-mitochondrial oxygen consumption by regulating RNF213 to promote tumour survival during hypoxia. Nature Cell Biology. 18(7), 803–813. https://doi.org/10.1038/ncb3376
   PubMed Web of Science ®Google Scholar
• Barone, G., Anderson, J., Pearson, A. D. J., Petrie, K., & Chesler, L. (2013). New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALK. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 19(21), 5814–5821. https://doi.org/10.1158/1078-0432.CCR-13-0680
   PubMed Web of Science ®Google Scholar
• Berko, E. R. (2017). De novo missense variants in HECW2 are associated with neurodevelopmental delay and hypotonia. Journal of Medical Genetics. 54(2), 84–86. https://doi.org/10.1136/jmedgenet-2016-103943
   PubMed Web of Science ®Google Scholar
• Bhardwaj, V. K., Oakley, A., & Purohit, R. (2022). Mechanistic behavior and subtle key events during DNA clamp opening and closing in T4 bacteriophage. International Journal of Biological Macromolecules, 208, 11–19. https://doi.org/10.1016/j.ijbiomac.2022.03.021
   PubMed Web of Science ®Google Scholar
• Boboila, S., Lopez, G., Yu, J., Banerjee, D., Kadenhe-Chiweshe, A., Connolly, E. P., Kandel, J. J., Rajbhandari, P., Silva, J. M., Califano, A., & Yamashiro, D. J. (2018). Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma. Oncogene, 37(40), 5451–5465. https://doi.org/10.1038/s41388-018-0326-9
   PubMed Web of Science ®Google Scholar
• Bourdeaut, F., Janoueix-Lerosey, I., Lucchesi, C., Paris, R., Ribeiro, A., de Pontual, L., Amiel, J., Lyonnet, S., Pierron, G., Michon, J., Peuchmaur, M., & Delattre, O. (2009). Cholinergic switch associated with morphological differentiation in neuroblastoma. The Journal of Pathology, 219(4), 463–472. https://doi.org/10.1002/path.2614
   PubMed Web of Science ®Google Scholar
• Brodeur, G. M., & Bagatell, R. (2014). Mechanisms of neuroblastoma regression. Nature Reviews. Clinical Oncology, 11(12), 704–713. https://doi.org/10.1038/nrclinonc.2014.168
   PubMed Web of Science ®Google Scholar
• Chen, B., Hua, Z., Gong, B., Tan, X., Zhang, S., Li, Q., Chen, Y., Zhang, J., & Li, Z. (2020). Downregulation of PIF1, a potential new target of MYCN, induces apoptosis and inhibits cell migration in neuroblastoma cells. Life Sciences, 256, 117820. https://doi.org/10.1016/j.lfs.2020.117820
   PubMed Web of Science ®Google Scholar
• Chen, B., Hua, Z., Qin, X., & Li, Z. (2021). Integrated microarray to identify the hub miRNAs and constructed miRNA-mRNA network in neuroblastoma via bioinformatics analysis. Neurochemical Research, 46(2), 197–212. https://doi.org/10.1007/s11064-020-03155-3
   PubMed Web of Science ®Google Scholar
• Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003). DAVID: Database for annotation, visualization, and integrated discovery. Genome Biology, 4(5), P3. https://doi.org/10.1186/gb-2003-4-5-p3
   PubMed Web of Science ®Google Scholar
• Ebadfardzadeh, J., Kazemi, M., Aghazadeh, A., Rezaei, M., Shirvaliloo, M., & Sheervalilou, R. (2021). Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer. Medical Oncology (Northwood, London, England), 38(9), 114. https://doi.org/10.1007/s12032-021-01543-5
   PubMed Web of Science ®Google Scholar
• Edgar, R., & Barrett, T. (2006). NCBI GEO standards and services for microarray data. Nature Biotechnology, 24(12), 1471–1472. https://doi.org/10.1038/nbt1206-1471
   PubMed Web of Science ®Google Scholar
• Evan, G. I., & Vousden, K. H. (2001). Proliferation, cell cycle and apoptosis in cancer. Nature, 411(6835), 342–348. https://doi.org/10.1038/35077213
   PubMed Web of Science ®Google Scholar
• Fletcher, J. I., Ziegler, D. S., Trahair, T. N., Marshall, G. M., Haber, M., & Norris, M. D. (2018). Too many targets, not enough patients: Rethinking neuroblastoma clinical trials. Nature Reviews. Cancer, 18(6), 389–400. https://doi.org/10.1038/s41568-018-0003-x
   PubMed Web of Science ®Google Scholar
• Gao, Y., Huo, W., Zhang, L., Lian, J., Tao, W., Song, C., Tang, J., Shi, S., & Gao, Y. (2019). Multiplex measurement of twelve tumor markers using a GMR multi-biomarker immunoassay biosensor. Biosensors & Bioelectronics, 123, 204–210. https://doi.org/10.1016/j.bios.2018.08.060
   PubMed Web of Science ®Google Scholar
• Gordan, J. D., Thompson, C. B., & Simon, M. C. (2007). HIF and c-Myc: Sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell, 12(2), 108–113. https://doi.org/10.1016/j.ccr.2007.07.006
   PubMed Web of Science ®Google Scholar
• Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646–674. https://doi.org/10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• He, J. (2020). BTB/POZ zinc finger protein ZBTB16 inhibits breast cancer proliferation and metastasis through upregulating ZBTB28 and antagonizing BCL6/ZBTB27. Clin Epigenetics, 12(1), 82. https://doi.org/10.1186/s13148-020-00867-9
   PubMed Web of Science ®Google Scholar
• Henrich, K.-O., Bender, S., Saadati, M., Dreidax, D., Gartlgruber, M., Shao, C., Herrmann, C., Wiesenfarth, M., Parzonka, M., Wehrmann, L., Fischer, M., Duffy, D. J., Bell, E., Torkov, A., Schmezer, P., Plass, C., Höfer, T., Benner, A., Pfister, S. M., & Westermann, F. (2016). Integrative genome-scale analysis identifies epigenetic mechanisms of transcriptional deregulation in unfavorable neuroblastomas. Cancer Research, 76(18), 5523–5537. https://doi.org/10.1158/0008-5472.CAN-15-2507
   PubMed Web of Science ®Google Scholar
• Hoehner, J. C., Gestblom, C., Hedborg, F., Sandstedt, B., Olsen, L., & Påhlman, S. (1996). A developmental model of neuroblastoma: Differentiating stroma-poor tumors’ progress along an extra-adrenal chromaffin lineage. Laboratory Investigation; a Journal of Technical Methods and Pathology, 75(5), 659–675.
   PubMed Web of Science ®Google Scholar
• Hong, M., He, J., Li, D., Chu, Y., Pu, J., Tong, Q., Joshi, H. C., Tang, S., & Li, S. (2020). Runt-related transcription factor 1 promotes apoptosis and inhibits neuroblastoma progression in vitro and in vivo. Journal of Experimental & Clinical Cancer Research: CR, 39(1), 52. https://doi.org/10.1186/s13046-020-01558-2
   PubMed Web of Science ®Google Scholar
• Hynes-Smith, R. W., Swenson, S. A., Vahle, H., Wittorf, K. J., Caplan, M., Amador, C., & Buckley, S. M. (2019). Loss of FBXO9 enhances proteasome activity and promotes aggressiveness in acute myeloid leukemia. Cancers (Basel, 11(11), 1717. https://doi.org/10.3390/cancers11111717
   PubMed Web of Science ®Google Scholar
• Janoueix-Lerosey, I., Lequin, D., Brugières, L., Ribeiro, A., de Pontual, L., Combaret, V., Raynal, V., Puisieux, A., Schleiermacher, G., Pierron, G., Valteau-Couanet, D., Frebourg, T., Michon, J., Lyonnet, S., Amiel, J., & Delattre, O. (2008). Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature, 455(7215), 967–970. https://doi.org/10.1038/nature07398
   PubMed Web of Science ®Google Scholar
• Kehl, T., Kern, F., Backes, C., Fehlmann, T., Stöckel, D., Meese, E., Lenhof, H.-P., & Keller, A. (2020). miRPathDB 2.0: A novel release of the miRNA pathway dictionary database. Nucleic Acids Research, 48(D1), D142–D147. https://doi.org/10.1093/nar/gkz1022
   PubMed Web of Science ®Google Scholar
• Kholodenko, I. V., Kalinovsky, D. V., Doronin, I. I., Deyev, S. M., & Kholodenko, R. V. (2018). Neuroblastoma origin and therapeutic targets for immunotherapy. Journal of Immunology Research, 2018, 7394268.
   PubMed Web of Science ®Google Scholar
• Kumar, S., Bhardwaj, V. K., Singh, R., Das, P., & Purohit, R. (2022). Identification of acridinedione scaffolds as potential inhibitor of DENV-2 C protein: An in silico strategy to combat dengue. Journal of Cellular Biochemistry, 123(5), 935–946. https://doi.org/10.1002/jcb.30237
   PubMed Web of Science ®Google Scholar
• Kundu, A., Bag, S., Ramaiah, S., & Anbarasu, A. (2013). Leucine to proline substitution by SNP at position 197 in Caspase-9 gene expression leads to neuroblastoma: A bioinformatics analysis. 3 Biotech, 3(3), 225–234. https://doi.org/10.1007/s13205-012-0088-y
   PubMedGoogle Scholar
• Lampis, S., Raieli, S., Montemurro, L., Bartolucci, D., Amadesi, C., Bortolotti, S., Angelucci, S., Scardovi, A. L., Nieddu, G., Cerisoli, L., Paganelli, F., Valente, S., Fischer, M., Martelli, A. M., Pasquinelli, G., Pession, A., Hrelia, P., & Tonelli, R. (2022). The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma. Journal of Experimental & Clinical Cancer Research: CR, 41(1), 160. https://doi.org/10.1186/s13046-022-02367-5
   PubMed Web of Science ®Google Scholar
• Lastowska, M. (2007). Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data. Oncogene, 26(53), 7432–7444.
   PubMed Web of Science ®Google Scholar
• Lawrence, G. W., Zurawski, T. H., Dong, X., & Dolly, J. O. (2021). Population Coding of Capsaicin Concentration by Sensory Neurons Revealed Using Ca(2+) Imaging of Dorsal Root Ganglia Explants from Adult pirt-GCaMP3 Mouse. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 55(4), 428–448. https://doi.org/10.33594/000000394
   PubMedGoogle Scholar
• Li, X. (2020). Mib2 deficiency inhibits microglial activation and alleviates ischemia-induced brain injury. Aging Dis, 11(3), 523–535. https://doi.org/10.14336/AD.2019.0807
   PubMed Web of Science ®Google Scholar
• Liang, C. (2018). TRIM36, a novel androgen-responsive gene, enhances anti-androgen efficacy against prostate cancer by inhibiting MAPK/ERK signaling pathways. Cell Death and Disease, 9(2), 155. https://doi.org/10.1038/s41419-017-0197-y
   PubMedGoogle Scholar
• Liu, J. A. (2020). Fbxo9 functions downstream of Sox10 to determine neuron-glial fate choice in the dorsal root ganglia through Neurog2 destabilization. Proceedings of the National Academy of Sciences of the United States of America, 117(8), 4199–4210. https://doi.org/10.1073/pnas.1916164117
   PubMed Web of Science ®Google Scholar
• Maris, J., M. (2010). Recent advances in neuroblastoma. The New England Journal of Medicine, 362(23), 2202–2211. https://doi.org/10.1056/NEJMra0804577
   PubMed Web of Science ®Google Scholar
• Marshall, G. M., Carter, D. R., Cheung, B. B., Liu, T., Mateos, M. K., Meyerowitz, J. G., & Weiss, W. A. (2014). The prenatal origins of cancer. Nature Reviews. Cancer, 14(4), 277–289. https://doi.org/10.1038/nrc3679
   PubMed Web of Science ®Google Scholar
• Martins-Neves, S. R., Paiva-Oliveira, D. I., Wijers-Koster, P. M., Abrunhosa, A. J., Fontes-Ribeiro, C., Bovée, J. V. M. G., Cleton-Jansen, A.-M., & Gomes, C. M. F. (2016). Chemotherapy induces stemness in osteosarcoma cells through activation of Wnt/beta-catenin signaling. Cancer Letters, 370(2), 286–295. https://doi.org/10.1016/j.canlet.2015.11.013
   PubMed Web of Science ®Google Scholar
• Masso-Valles, D., Beaulieu, M. E., & Soucek, L. (2020). MYC, MYCL, and MYCN as therapeutic targets in lung cancer. Expert Opinion on Therapeutic Targets, 24(2), 101–114. https://doi.org/10.1080/14728222.2020.1723548
   PubMed Web of Science ®Google Scholar
• Matthay, K. K., Maris, J. M., Schleiermacher, G., Nakagawara, A., Mackall, C. L., Diller, L., & Weiss, W. A. (2016). Neuroblastoma. Nature Reviews. Disease Primers, 2, 16078. https://doi.org/10.1038/nrdp.2016.78
   PubMed Web of Science ®Google Scholar
• Montemurro, L., Raieli, S., Angelucci, S., Bartolucci, D., Amadesi, C., Lampis, S., Scardovi, A. L., Venturelli, L., Nieddu, G., Cerisoli, L., Fischer, M., Teti, G., Falconi, M., Pession, A., Hrelia, P., & Tonelli, R. (2019). A novel MYCN-specific antigene oligonucleotide deregulates mitochondria and inhibits tumor growth in MYCN-amplified neuroblastoma. Cancer Research, 79(24), 6166–6177. https://doi.org/10.1158/0008-5472.CAN-19-0008
   PubMed Web of Science ®Google Scholar
• Mus, L. M., Lambertz, I., Claeys, S., Kumps, C., Van Loocke, W., Van Neste, C., Umapathy, G., Vaapil, M., Bartenhagen, C., Laureys, G., De Wever, O., Bexell, D., Fischer, M., Hallberg, B., Schulte, J., De Wilde, B., Durinck, K., Denecker, G., De Preter, K., & Speleman, F. (2020). The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness. Scientific Reports, 10(1), 218. https://doi.org/10.1038/s41598-019-57076-5
   PubMed Web of Science ®Google Scholar
• Nolan, J. C., Salvucci, M., Carberry, S., Barat, A., Segura, M. F., Fenn, J., Prehn, J. H. M., Stallings, R. L., & Piskareva, O. (2020). A context-dependent role for MiR-124-3p on cell phenotype, viability and chemosensitivity in neuroblastoma in vitro. Frontiers in Cell and Developmental Biology, 8, 559553. https://doi.org/10.3389/fcell.2020.559553
   PubMed Web of Science ®Google Scholar
• Ohtaki, M., Otani, K., Hiyama, K., Kamei, N., Satoh, K., & Hiyama, E. (2010). A robust method for estimating gene expression states using Affymetrix microarray probe level data. BMC Bioinformatics, 11, 183.
   PubMed Web of Science ®Google Scholar
• Otte, J., Dyberg, C., Pepich, A., & Johnsen, J. I. (2020). MYCN function in neuroblastoma development. Frontiers in Oncology, 10, 624079.
   PubMed Web of Science ®Google Scholar
• Panachan, J., Rojsirikulchai, N., Pongsakul, N., Khowawisetsut, L., Pongphitcha, P., Siriboonpiputtana, T., Chareonsirisuthigul, T., Phornsarayuth, P., Klinkulab, N., Jinawath, N., Chiangjong, W., Anurathapan, U., Pattanapanyasat, K., Hongeng, S., & Chutipongtanate, S. (2022). Extracellular vesicle-based method for detecting MYCN amplification status of pediatric neuroblastoma. Cancers, 14(11), 2627. https://doi.org/10.3390/cancers14112627
   PubMed Web of Science ®Google Scholar
• Piccolo, P. (2017). MIB2 variants altering NOTCH signalling result in left ventricle hypertrabeculation/non-compaction and are associated with Menetrier-like gastropathy. Human Molecular Genetics, 26(1), 33–43. https://doi.org/10.1093/hmg/ddw365
   PubMed Web of Science ®Google Scholar
• Pinto, N. R., Applebaum, M. A., Volchenboum, S. L., Matthay, K. K., London, W. B., Ambros, P. F., Nakagawara, A., Berthold, F., Schleiermacher, G., Park, J. R., Valteau-Couanet, D., Pearson, A. D. J., & Cohn, S. L. (2015). Advances in risk classification and treatment strategies for neuroblastoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 33(27), 3008–3017. https://doi.org/10.1200/JCO.2014.59.4648
   PubMed Web of Science ®Google Scholar
• Ponzoni, M., Bachetti, T., Corrias, M. V., Brignole, C., Pastorino, F., Calarco, E., Bensa, V., Giusto, E., Ceccherini, I., & Perri, P. (2022). Recent advances in the developmental origin of neuroblastoma: An overview. Journal of Experimental & Clinical Cancer Research: CR, 41(1), 92. https://doi.org/10.1186/s13046-022-02281-w
   PubMed Web of Science ®Google Scholar
• Pottoo, F. H., Barkat, M. A., Ansari, M. A., Javed, M. N., Sajid Jamal, Q. M., Kamal., & M. A., Harshita. (2021). Nanotechnological based miRNA intervention in the therapeutic management of neuroblastoma. Seminars in Cancer Biology, 69, 100–108. https://doi.org/10.1016/j.semcancer.2019.09.017
   PubMed Web of Science ®Google Scholar
• Qu, H., Zheng, L., Pu, J., Mei, H., Xiang, X., Zhao, X., Li, D., Li, S., Mao, L., Huang, K., & Tong, Q. (2015). miRNA-558 promotes tumorigenesis and aggressiveness of neuroblastoma cells through activating the transcription of heparanase. Human Molecular Genetics, 24(9), 2539–2551. https://doi.org/10.1093/hmg/ddv018
   PubMed Web of Science ®Google Scholar
• Rickman, D. S., Schulte, J. H., & Eilers, M. (2018). The expanding world of N-MYC-driven tumors. Cancer Discovery, 8(2), 150–163. https://doi.org/10.1158/2159-8290.CD-17-0273
   PubMed Web of Science ®Google Scholar
• Roth, M., Goerke, P., Holtmann, C., Frings, A., MacKenzie, C. R., & Geerling, G. (2022). Spectrum and resistance in bacterial infections of the ocular surface in a German tertiary referral center 2009-2019. Graefe’s Archive for Clinical and Experimental Ophthalmology, https://doi.org/10.1007/s00417-022-05721-7
   Google Scholar
• Saletta, F., Seng, M. S., & Lau, L. M. (2014). Advances in paediatric cancer treatment. Translational Pediatrics, 3(2), 156–182.
   PubMedGoogle Scholar
• Salmi, A., Quacquarelli, F., Chauveau, C., Clabaut, A., & Broux, O. (2022). An integrative bioinformatics approach to decipher adipocyte-induced transdifferentiation of osteoblast. Genomics, 114(4), 110422. https://doi.org/10.1016/j.ygeno.2022.110422
   PubMed Web of Science ®Google Scholar
• Schmittgen, T. D. (2019). Exosomal miRNA cargo as mediator of immune escape mechanisms in neuroblastoma. Cancer Research, 79(7), 1293–1294. https://doi.org/10.1158/0008-5472.CAN-19-0021
   PubMed Web of Science ®Google Scholar
• Schulpen, M., Visser, O., Reedijk, A. M. J., Kremer, L. C. M., Zwaan, C. M., Eggermont, A. M. M., Coebergh, J. W., Pieters, R., & Karim-Kos, H. E. (2021). Significant improvement in survival of advanced stage childhood and young adolescent cancer in the Netherlands since the 1990s. European Journal of Cancer (Oxford, England: 1990), 157, 81–93. https://doi.org/10.1016/j.ejca.2021.08.001
   PubMed Web of Science ®Google Scholar
• Schulte, J. H., Kirfel, J., Lim, S., Schramm, A., Friedrichs, N., Deubzer, H. E., Witt, O., Eggert, A., & Buettner, R. (2008). Transcription factor AP2alpha (TFAP2a) regulates differentiation and proliferation of neuroblastoma cells. Cancer Letters, 271(1), 56–63. https://doi.org/10.1016/j.canlet.2008.05.039
   PubMed Web of Science ®Google Scholar
• Seier, J. A., Reinhardt, J., Saraf, K., Ng, S. S., Layer, J. P., Corvino, D., Althoff, K., Giordano, F. A., Schramm, A., Fischer, M., & Hölzel, M. (2021). Druggable epigenetic suppression of interferon-induced chemokine expression linked to MYCN amplification in neuroblastoma. Journal for ImmunoTherapy of Cancer, 9(5), e001335. https://doi.org/10.1136/jitc-2020-001335
   PubMed Web of Science ®Google Scholar
• Seok, J. (2021). Multi-omics analysis of SOX4, SOX11, and SOX12 expression and the associated pathways in human cancers. Journal of Personalized Medicine, 11(8), 823. https://doi.org/10.3390/jpm11080823.
   Google Scholar
• Shohet, J. M. (2012). Redefining functional MYCN gene signatures in neuroblastoma. Proceedings of the National Academy of Sciences of the United States of America, 109(47), 19041–19042. https://doi.org/10.1073/pnas.1217598109
   PubMed Web of Science ®Google Scholar
• Singh, R., Bhardwaj, V. K., & Purohit, R. (2022). Computational targeting of allosteric site of MEK1 by quinoline-based molecules. Cell Biochemistry and Function, 40(5), 481-490. https://doi.org/10.1002/cbf.3709.
   Google Scholar
• Singh, R., Bhardwaj, V. K., Das, P., & Purohit, R. (2022). Identification of 11beta-HSD1 inhibitors through enhanced sampling methods. Chemical Communications (Cambridge, England), 58(32), 5005–5008. https://doi.org/10.1039/d1cc06894f
   PubMed Web of Science ®Google Scholar
• Takasawa, S. (2022). Intermittent hypoxia increased the expression of DBH and PNMT in neuroblastoma cells via MICRORNA-375-mediated mechanism. International Journal of Molecular Sciences, 23(11). 5868. https://doi.org/10.3390/ijms23115868.
   Google Scholar
• Tao, L., Mohammad, M. A., Milazzo, G., Moreno-Smith, M., Patel, T. D., Zorman, B., Badachhape, A., Hernandez, B. E., Wolf, A. B., Zeng, Z., Foster, J. H., Aloisi, S., Sumazin, P., Zu, Y., Hicks, J., Ghaghada, K. B., Putluri, N., Perini, G., Coarfa, C., & Barbieri, E. (2022). MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma. Nature Communications, 13(1), 3728. https://doi.org/10.1038/s41467-022-31331-2
   PubMed Web of Science ®Google Scholar
• Wang, X. (2020). RNF213 suppresses carcinogenesis in glioblastoma by affecting MAPK/JNK signaling pathway. Clinical and Translational Oncology, 22(9), 1506–1516. https://doi.org/10.1007/s12094-020-02286-x
   PubMed Web of Science ®Google Scholar
• Westermark, U. K., Wilhelm, M., Frenzel, A., & Henriksson, M. A. (2011). The MYCN oncogene and differentiation in neuroblastoma. Seminars in Cancer Biology, 21(4), 256–266. https://doi.org/10.1016/j.semcancer.2011.08.001
   PubMed Web of Science ®Google Scholar
• Xia, J., Benner, M. J., & Hancock, R. E. (2014). NetworkAnalyst–integrative approaches for protein-protein interaction network analysis and visual exploration. Nucleic Acids Research, 42(Web Server issue), W167–74. https://doi.org/10.1093/nar/gku443
   PubMedGoogle Scholar
• Xia, M., Liu, D., Liu, H., Peng, L., Yang, D., Tang, C., Chen, G., Liu, Y., & Liu, H. (2022). Identification of hub genes and therapeutic agents for IgA nephropathy through bioinformatics analysis and experimental validation. Frontiers in Medicine, 9, 881322.),
   Web of Science ®Google Scholar
• Xiao, G.-Q., Priemer, D. S., Wei, C., Aron, M., Yang, Q., & Idrees, M. T. (2017). ZBTB16 is a sensitive and specific marker in detection of metastatic and extragonadal yolk sac tumour. Histopathology, 71(4), 562–569. https://doi.org/10.1111/his.13276
   PubMed Web of Science ®Google Scholar
• Yang, L. (2018). Engagement of circular RNA HECW2 in the nonautophagic role of ATG5 implicated in the endothelial-mesenchymal transition. Autophagy, 14(3), 404–418. https://doi.org/10.1080/15548627.2017.1414755
   PubMed Web of Science ®Google Scholar
• Yang, Y., Zhao, J., Zhang, Y., Feng, T., Yv, B., Wang, J., Gao, Y., Yin, M., Tang, J., & Li, Y. (2022). MYCN protein stability is a better prognostic indicator in neuroblastoma. BMC Pediatrics, 22(1), 404. https://doi.org/10.1186/s12887-022-03449-1
   PubMed Web of Science ®Google Scholar
• Zhang, D., Li, B., Guo, R., Wu, J., Yang, C., Jiang, X., Zhang, C., Yan, H., Zhao, Q., Wang, Z., Wang, Q., Huang, R., Zhang, Z., Hu, X., & Gao, L. (2021). RAB5C, SYNJ1, and RNF19B promote male ankylosing spondylitis by regulating immune cell infiltration. Annals of Translational Medicine, 9(12), 1011. https://doi.org/10.21037/atm-21-2721
   PubMed Web of Science ®Google Scholar
• Zhou, S., Lu, H., & Xiong, M. (2021). Identifying immune cell infiltration and effective diagnostic biomarkers in rheumatoid arthritis by. Frontiers in Immunology, 12, 726747.
   PubMed Web of Science ®Google Scholar